CD56 and high molecular weight cytokeratin as diagnostic markers of papillary thyroid carcinoma

Korean Journal of Pathology

Volumn 45, Issue 5, 2011, Pages 477-484

  Shin, Mi Kyung ^a   Kim, Jeong Won ^a   Ju, Young Su ^b  

^a Hallym University Medical Center   (South Korea)

^b Hallym University College of Medicine   (South Korea)

Author keywords

CD56; High molecular weight cytokeratin; Thyroid papillary carcinoma

Indexed keywords

EID: 84863047995     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2011.45.5.477     Document Type: Article

References (19)

1. Kim SK, Hwang TS, Yoo YB, et al. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab 2011; 96: 658-64.
2. Park WY, Jeong SM, Lee JH, et al. Diagnostic value of decreased expression of CD56 protein in papillary carcinoma of the thyroid gland. Basic Appl Pathol 2009; 2: 63-8.
3. Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining. Mod Pathol 2006; 19: 1631-7.
4. El Demellawy D, Nasr AL, Babay S, Alowami S. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid. Pathol Res Pract 2009; 205: 303-9.
5. Migita K, Eguchi K, Kawakami A, et al. Detection of Leu-19 (CD56) antigen on human thyroid epithelial cells by an immunohistochemical method. Immunology 1991; 72: 246-9.
6. El Demellawy D, Nasr A, Alowami S. Application of CD56, p63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid. Diagn Pathol 2008; 3: 5.
7. Scarpino S, Di Napoli A, Melotti F, Talerico C, Cancrini A, Ruco L. Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells. J Pathol 2007; 212: 411-9.
8. Zeromski J, Biczysko M, Stajgis P, Lawniczak M, Biczysko W. CD56 (NCAM) antigen in glandular epithelium of human thyroid: light microscopic and ultrastructural study. Folia Histochem Cytobiol 1999; 37: 11-7.
9. Liberman E, Weidner N. Papillary and follicular neoplasms of the thyroid gland: differential immunohistochemical staining with high-molecular-weight keratin and involucrin. Appl Immunohistochem Mol Morphol 2000; 8: 42-8.
10. Raphael SJ, Apel RL, Asa SL. Brief report: detection of high-molecular-weight cytokeratins in neoplastic and non-neoplastic thyroid tumors using microwave antigen retrieval. Mod Pathol 1995; 8: 870-2.
11. Raphael SJ, McKeown-Eyssen G, Asa SL. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod Pathol 1994; 7: 295-300.
12. Choi YL, Kim MK, Suh JW, et al. Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcrip tion factor-1, and E-cadherin in thyroid carcinomas. J Korean Med Sci 2005; 20: 853-9.
13. Park YJ, Kwak SH, Kim DC, et al. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules. J Korean Med Sci 2007; 22: 621-8.
14. Takenaka Y, Inohara H, Yoshii T, et al. Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett 2003; 195: 111-9.
15. Bernet VJ, Anderson J, Vaishnav Y, et al. Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2002; 87: 4792-6.
16. Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 2002; 87: 4806-10.
17. Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N. Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors. Cancer Lett 2003; 199: 69-73.
18. Mehrotra P, Okpokam A, Bouhaidar R, et al. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 2004; 45: 493-500.
19. Satoh F, Umemura S, Yasuda M, Osamura RY. Neuroendocrine marker expression in thyroid epithelial tumors. Endocr Pathol 2001; 12: 291-9.